logo
#

Latest news with #KebNi

European Penny Stocks To Watch In June 2025
European Penny Stocks To Watch In June 2025

Yahoo

time3 days ago

  • Business
  • Yahoo

European Penny Stocks To Watch In June 2025

European markets have seen a modest uptick, with the STOXX Europe 600 Index gaining 0.65% as optimism grows over potential trade negotiations and slowing inflation prompts expectations of an interest rate cut by the European Central Bank. As investors navigate these evolving conditions, penny stocks—often smaller or newer companies—remain an intriguing option for those seeking growth opportunities outside the mainstream indices. Despite being considered a relic of past market eras, penny stocks continue to offer potential when backed by strong financial health, making them worth watching for their affordability and growth prospects. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.325 SEK2.23B ★★★★☆☆ KebNi (OM:KEBNI B) SEK1.818 SEK492.96M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.69 SEK276.69M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.64 SEK221.45M ★★★★★★ Abak (WSE:ABK) PLN4.20 PLN11.32M ★★★★★★ Cellularline (BIT:CELL) €2.93 €61.8M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.948 €31.75M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.67 €17.46M ★★★★★★ Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.17 €299.6M ★★★★★★ Click here to see the full list of 447 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Antares Vision S.p.A. specializes in the production, installation, and maintenance of inspection systems for quality control and has a market cap of €320.63 million. Operations: The company's revenue segment includes Industrial Automation & Controls, which generated €207.66 million. Market Cap: €320.63M Antares Vision S.p.A. has a market cap of €320.63 million and reported sales of €207.49 million for 2024, though it remains unprofitable with a net loss of €18.77 million. Despite this, the company maintains a sufficient cash runway exceeding three years, supported by positive free cash flow and stable short-term assets (€176.4M) that cover both short-term (€109.6M) and long-term liabilities (€150.2M). However, its management team is relatively new with an average tenure of 1.4 years, and the net debt to equity ratio is high at 45.2%. Earnings are forecast to grow significantly at 93% annually despite past losses increasing over five years by a large margin. Unlock comprehensive insights into our analysis of Antares Vision stock in this financial health report. Evaluate Antares Vision's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Aiforia Technologies Oyj, along with its subsidiary Aiforia Inc., provides deep learning AI software to assist pathologists and scientists in various labs globally, with a market cap of €106.35 million. Operations: The company generates revenue primarily from its Healthcare Software segment, amounting to €2.85 million. Market Cap: €106.35M Aiforia Technologies Oyj, with a market cap of €106.35 million, is navigating the penny stock landscape by leveraging its AI-assisted pathology solutions. Despite being unprofitable and having a modest revenue of €2.85 million, Aiforia's financial health is bolstered by short-term assets (€13.2M) exceeding liabilities and more cash than debt. Recent strategic partnerships with institutions like Nantes University Hospital and USCAP highlight its expanding footprint in digital pathology. The company recently raised €8 million through equity offerings, extending its cash runway to support operations amid management changes and ongoing efforts to enhance product adoption globally. Take a closer look at Aiforia Technologies Oyj's potential here in our financial health report. Gain insights into Aiforia Technologies Oyj's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: KebNi AB (publ) is a company that develops, produces, and sells stabilization, navigation, and satellite communication products globally with a market cap of SEK492.96 million. Operations: The company's revenue is primarily derived from its Unclassified Services segment, amounting to SEK141.66 million. Market Cap: SEK492.96M KebNi AB, with a market cap of SEK492.96 million, is making strides in the penny stock sector through its satellite communication products and stabilization technology. The company has recently secured a significant order from Saab worth 134 MSEK for its Inertial Measurement Units, contributing to total orders of 348 MSEK over 30 months. Despite past volatility and insider selling, KebNi's financial position remains robust with short-term assets exceeding liabilities and no debt burden. While profitability has been achieved recently, earnings growth comparisons are challenging due to large one-off losses impacting results up to March 2025. Click here to discover the nuances of KebNi with our detailed analytical financial health report. Gain insights into KebNi's future direction by reviewing our growth report. Investigate our full lineup of 447 European Penny Stocks right here. Curious About Other Options? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:AV HLSE:AIFORIA and OM:KEBNI B. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

European Growth Stocks With Strong Insider Ownership In June 2025
European Growth Stocks With Strong Insider Ownership In June 2025

Yahoo

time3 days ago

  • Business
  • Yahoo

European Growth Stocks With Strong Insider Ownership In June 2025

As European markets navigate the complexities of trade negotiations and inflationary pressures, investor attention is increasingly drawn to growth companies with substantial insider ownership. In such an environment, stocks that boast strong insider confidence can offer a compelling proposition for investors seeking alignment of interests and potential resilience amidst economic uncertainties. Name Insider Ownership Earnings Growth CTT Systems (OM:CTT) 17.5% 34.2% KebNi (OM:KEBNI B) 38.3% 67% Yubico (OM:YUBICO) 36.2% 30.4% Pharma Mar (BME:PHM) 11.8% 43.1% Bonesupport Holding (OM:BONEX) 10.4% 56.1% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Lokotech Group (OB:LOKO) 14.8% 58.1% Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Diamyd Medical (OM:DMYD B) 11.9% 93% Elliptic Laboratories (OB:ELABS) 22.9% 79% Click here to see the full list of 211 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★★☆ Overview: NTG Nordic Transport Group A/S, with a market cap of DKK4.45 billion, offers asset-light freight forwarding services across road, rail, air, and ocean in Denmark, Sweden, the United States, Germany, Finland, and internationally. Operations: The company's revenue is primarily derived from two segments: Air & Ocean, which contributes DKK2.89 billion, and Road & Logistics, which accounts for DKK7.04 billion. Insider Ownership: 24.6% Earnings Growth Forecast: 20.8% p.a. NTG Nordic Transport Group shows potential as a growth company with high insider ownership. Despite recent declines in net income and profit margins, NTG's earnings are forecast to grow significantly at 20.8% annually, outpacing the Danish market. The company is trading well below its estimated fair value, suggesting room for price appreciation. However, it faces challenges with high debt levels and slower revenue growth at 8.5% annually compared to its ambitious M&A strategy aimed at scaling operations further across Europe and globally. Click to explore a detailed breakdown of our findings in NTG Nordic Transport Group's earnings growth report. Insights from our recent valuation report point to the potential undervaluation of NTG Nordic Transport Group shares in the market. Simply Wall St Growth Rating: ★★★★★☆ Overview: Edda Wind ASA develops, builds, owns, operates, and charters purpose-built service operation vessels (SOVs) and commissioning service operation vessels (CSOVs) for offshore wind farms and maritime operations globally, with a market cap of NOK2.94 billion. Operations: The company's revenue segment is primarily derived from the Offshore Wind Segment, generating €79.42 million. Insider Ownership: 29.6% Earnings Growth Forecast: 94.6% p.a. Edda Wind is experiencing rapid growth, with earnings forecasted to increase significantly at 94.6% annually, well above the Norwegian market average. Revenue is also expected to grow robustly at 33.1% per year. However, recent results show a decline in net income and profit margins compared to last year. The company has a volatile share price and faces challenges with debt coverage by operating cash flow. A proposed acquisition could lead to delisting from the Oslo Stock Exchange. Click here and access our complete growth analysis report to understand the dynamics of Edda Wind. Our valuation report unveils the possibility Edda Wind's shares may be trading at a premium. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Semperit Aktiengesellschaft Holding is a company that develops, produces, and sells rubber products for the medical and industrial sectors globally, with a market cap of €290.09 million. Operations: The company's revenue is generated from its Semperit Engineered Applications segment, which accounts for €361.97 million, and its Semperit Industrial Applications segment, contributing €290.48 million. Insider Ownership: 10.1% Earnings Growth Forecast: 85.3% p.a. Semperit Holding, with substantial insider ownership, is forecasted to experience significant earnings growth of 85.31% annually, outpacing the Austrian market. However, its revenue growth of 7.2% per year is slower than desired for high-growth companies and recent financial results show a net loss of €7.2 million for Q1 2025 compared to a profit last year. The company's share price has been highly volatile recently and its dividend yield isn't well covered by earnings. Unlock comprehensive insights into our analysis of Semperit Holding stock in this growth report. According our valuation report, there's an indication that Semperit Holding's share price might be on the cheaper side. Click this link to deep-dive into the 211 companies within our Fast Growing European Companies With High Insider Ownership screener. Ready For A Different Approach? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include CPSE:NTG OB:EWIND and WBAG:SEM. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

High Growth Tech Stocks In Europe May 2025
High Growth Tech Stocks In Europe May 2025

Yahoo

time28-05-2025

  • Business
  • Yahoo

High Growth Tech Stocks In Europe May 2025

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index ending a streak of gains due to proposed U.S. tariffs on EU goods, while economic growth forecasts have been revised downward amid rising uncertainties. In this environment, identifying high-growth tech stocks involves looking for companies that can navigate trade tensions and leverage innovation to maintain robust performance despite broader market pressures. Name Revenue Growth Earnings Growth Growth Rating KebNi 21.51% 66.96% ★★★★★★ Intellego Technologies 31.55% 51.31% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ Yubico 20.18% 30.36% ★★★★★★ Pharma Mar 26.03% 43.09% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ CD Projekt 33.21% 37.35% ★★★★★★ XTPL 86.66% 143.68% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lumibird SA is a company that specializes in designing, manufacturing, and selling lasers for scientific, industrial, and medical applications globally, with a market capitalization of €330.14 million. Operations: The company generates revenue from two main segments: Medical (€107.75 million) and Photonic (€99.37 million). Lumibird, a player in the European tech scene, has demonstrated a mixed financial trajectory recently. Despite a challenging year with earnings declining by 20.1%, forecasts are optimistic with an expected annual earnings growth of 37.3%. This growth rate notably surpasses the French market's average of 12.1%. Additionally, Lumibird's revenue is also set to outpace the local market, projecting an increase of 7.1% per year compared to the broader market's 5%. However, it's crucial to note that past financial results have been impacted by a significant one-off loss of €3.4 million as of December 2024. With such dynamics at play, Lumibird presents both opportunities and risks within the high-growth tech sector in Europe. Click here and access our complete health analysis report to understand the dynamics of Lumibird. Examine Lumibird's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: BioInvent International AB (publ) is a clinical-stage company focused on discovering and developing novel immuno-modulatory antibodies for cancer treatment, with a market cap of approximately SEK2.43 billion. Operations: BioInvent focuses on developing antibody-based drugs, generating revenue of SEK60.80 million from this segment. The company operates in Sweden, Europe, the United States, and other international markets. BioInvent International, a Swedish biotech firm, is making notable strides in the high-growth tech sector in Europe with an impressive forecasted annual revenue growth rate of 76.6%, significantly outpacing the Swedish market's average of 4.2%. Despite being currently unprofitable, the company is expected to reach profitability within three years, reflecting an anticipated robust annual profit growth. Recent developments include promising Phase 2a study results of BI-1808 for Cutaneous T-cell Lymphoma presented at the EHA congress and FDA's Fast Track Designation for this innovative treatment, highlighting BioInvent's potential to transform therapeutic approaches in oncology through its focused R&D efforts which continue to attract significant investment and interest within the biotechnological landscape. Get an in-depth perspective on BioInvent International's performance by reading our health report here. Assess BioInvent International's past performance with our detailed historical performance reports. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Hanza AB (publ) is a company that offers manufacturing solutions, with a market capitalization of approximately SEK3.76 billion. Operations: The company generates revenue primarily from its Main Markets segment, which accounts for SEK2.92 billion, and Other Markets contributing SEK2.06 billion. The Business Development and Services segment adds SEK32 million to the total revenue. Hanza is distinguishing itself in the European tech sector with an annual revenue growth rate of 9.9%, outstripping the Swedish market average of 4.2%. Despite a challenging past year marked by a 38.1% earnings decline, forecasts suggest robust future earnings growth at an annual rate of 27.7%. The company's recent financials reveal a net income rise to SEK 40 million from SEK 34 million year-over-year, supported by sales increasing to SEK 1,326 million from SEK 1,253 million. These figures underscore Hanza's resilience and potential for sustained growth amidst market adversities. Unlock comprehensive insights into our analysis of Hanza stock in this health report. Explore historical data to track Hanza's performance over time in our Past section. Dive into all 226 of the European High Growth Tech and AI Stocks we have identified here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:LBIRD OM:BINV and OM:HANZA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

3 European Growth Companies With Insider Ownership Expecting Up To 115% Earnings Growth
3 European Growth Companies With Insider Ownership Expecting Up To 115% Earnings Growth

Yahoo

time27-05-2025

  • Business
  • Yahoo

3 European Growth Companies With Insider Ownership Expecting Up To 115% Earnings Growth

The European stock market recently experienced a downturn, with the pan-European STOXX Europe 600 Index ending lower amid trade tensions and economic uncertainty. In this environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the company's operations. Name Insider Ownership Earnings Growth KebNi (OM:KEBNI B) 38.3% 67% Yubico (OM:YUBICO) 36.2% 30.4% Pharma Mar (BME:PHM) 11.8% 43.1% Vow (OB:VOW) 13.1% 81% Bonesupport Holding (OM:BONEX) 10.4% 56.1% Bergen Carbon Solutions (OB:BCS) 12% 63.2% CD Projekt (WSE:CDR) 29.7% 37.4% Lokotech Group (OB:LOKO) 14.5% 58.1% XTPL (WSE:XTP) 23.3% 143.7% Elliptic Laboratories (OB:ELABS) 25.8% 79% Click here to see the full list of 213 stocks from our Fast Growing European Companies With High Insider Ownership screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €919.59 million. Operations: The company's revenue is segmented geographically with €176.26 million from the Americas, €134.84 million from the Asia-Pacific region, and €220.46 million from EMEA (Europe, Middle East and Africa). Insider Ownership: 12.7% Earnings Growth Forecast: 20.8% p.a. Lectra is poised for significant earnings growth, expected at 20.83% annually over the next three years, outpacing the French market. This aligns with its recent strategic expansion of the Valia Fashion platform into new global markets like Mexico and Brazil, enhancing production efficiency in apparel manufacturing. Despite a slight dip in Q1 earnings to €6.55 million from €7.17 million last year, analysts anticipate a 31.2% stock price increase, reflecting confidence in Lectra's growth trajectory and M&A potential. Click here to discover the nuances of Lectra with our detailed analytical future growth report. Insights from our recent valuation report point to the potential undervaluation of Lectra shares in the market. Simply Wall St Growth Rating: ★★★★★☆ Overview: MedinCell S.A. is a pharmaceutical company in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €555.12 million. Operations: MedinCell generates its revenue from the pharmaceuticals segment, amounting to €13.20 million. Insider Ownership: 13.9% Earnings Growth Forecast: 115.3% p.a. MedinCell's growth prospects are strong, with revenue expected to rise 68.4% annually, significantly outpacing the French market. Recent strategic alliances and product developments, such as the long-acting injectable Macozinone for tuberculosis and Olanzapine LAI for schizophrenia in partnership with Teva, bolster its pipeline. Despite negative shareholder equity, analysts predict a 33.4% stock price increase. High insider ownership aligns management interests with shareholders during this growth phase. Unlock comprehensive insights into our analysis of MedinCell stock in this growth report. The analysis detailed in our MedinCell valuation report hints at an deflated share price compared to its estimated value. Simply Wall St Growth Rating: ★★★★★☆ Overview: Stadler Rail AG, with a market cap of CHF2.12 billion, manufactures and sells trains across Switzerland, Germany, Austria, Western and Eastern Europe, the Americas, the CIS countries, and internationally through its subsidiaries. Operations: Stadler Rail AG generates revenue through its segments: Signalling (CHF109.11 million), Rolling Stock (CHF2.74 billion), and Service & Components (CHF866.43 million). Insider Ownership: 14.5% Earnings Growth Forecast: 43.3% p.a. Stadler Rail's growth outlook is promising, with earnings forecasted to grow significantly at 43.3% annually, surpassing the Swiss market average. Despite a decrease in net income and profit margins last year, revenue is expected to increase by 10.5% annually, outpacing the market's growth rate. The company's high insider ownership suggests alignment with shareholder interests as it navigates these challenges and opportunities for future expansion in the rail industry. Dive into the specifics of Stadler Rail here with our thorough growth forecast report. Insights from our recent valuation report point to the potential overvaluation of Stadler Rail shares in the market. Delve into our full catalog of 213 Fast Growing European Companies With High Insider Ownership here. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTPA:LSS ENXTPA:MEDCL and SWX:SRAIL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Exploring Three High Growth Tech Stocks in Europe
Exploring Three High Growth Tech Stocks in Europe

Yahoo

time26-05-2025

  • Business
  • Yahoo

Exploring Three High Growth Tech Stocks in Europe

The European market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index ending lower amid rising tariff threats from the U.S., which have contributed to economic uncertainty and a contraction in business activity. In this challenging environment, identifying high-growth tech stocks requires careful consideration of their ability to innovate and adapt to shifting trade dynamics while maintaining robust financial health and competitive positioning. Name Revenue Growth Earnings Growth Growth Rating KebNi 21.51% 66.96% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ Yubico 20.18% 30.36% ★★★★★★ Pharma Mar 25.21% 43.09% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ CD Projekt 33.48% 37.39% ★★★★★★ XTPL 86.66% 143.68% ★★★★★★ Xbrane Biopharma 24.95% 56.77% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Seco S.p.A. is a technology company that specializes in developing and delivering innovative solutions for the digitization of industrial products and processes across various regions including Italy, Europe, the Middle East, Africa, the United States, and Asia-Pacific, with a market cap of €331.13 million. Operations: Seco focuses on providing advanced technological solutions that enhance the digitization of industrial products and processes globally. The company operates in multiple regions, including Europe, the Middle East, Africa, the U.S., and Asia-Pacific. Seco S.p.A. stands out in the European tech landscape, not just for its commitment to innovation but also for its strategic movements in the market. Despite a recent net loss of €2.02 million in Q1 2025, down from a modest profit last year, the company's aggressive R&D investment strategy signals a robust blueprint for future growth; historically, such expenditures have been linked to fostering significant technological advancements. Moreover, with revenue projections set over €50 million for Q2 2025 and maintaining a gross profit margin target above 50%, Seco is positioning itself well against slower industry growth rates. The firm's participation in key Italian investment conferences further underscores its active role in shaping industry discussions and potential market opportunities. Click here and access our complete health analysis report to understand the dynamics of Seco. Evaluate Seco's historical performance by accessing our past performance report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Better Collective A/S operates as a digital sports media company across Europe, North America, and internationally, with a market capitalization of SEK7.71 billion. Operations: The company generates revenue primarily through affiliate marketing and advertising services within the sports betting industry. Its operations are centered on digital platforms that connect users with betting operators, leveraging data insights to enhance user engagement. The business model focuses on performance-based marketing, where earnings are tied to the success of referred customers. Better Collective A/S, a key figure in Europe's high-growth tech sector, is navigating through a transformative phase with notable financial dynamics. Despite a dip in Q1 2025 sales to €82.59 million from €95.03 million the previous year, the company maintains a robust earnings forecast with expected revenue between €320 million and €350 million for 2025. This outlook is supported by an aggressive R&D investment strategy that not only underscores its commitment to innovation but also aligns with its impressive annual earnings growth forecast of 30.9%. Moreover, Better Collective's strategic focus on enhancing interactive media and services has enabled it to outperform industry growth rates, positioning it well for future market expansions. Get an in-depth perspective on Better Collective's performance by reading our health report here. Review our historical performance report to gain insights into Better Collective's's past performance. Simply Wall St Growth Rating: ★★★★★☆ Overview: Cicor Technologies Ltd. is a global company that develops and manufactures electronic components, devices, and systems, with a market cap of CHF542.17 million. Operations: Cicor operates through two primary divisions: Advanced Substrates (AS) and Electronic Manufacturing Services (EMS), generating CHF45.31 million and CHF438.01 million in revenue, respectively. The EMS division is the larger contributor to the company's revenue stream. Cicor Technologies, a pivotal entity in Europe's tech landscape, particularly in aerospace and defense electronics, has demonstrated a robust trajectory with an earnings growth of 131.7% over the past year, significantly outpacing the industry average of 38.1%. This surge is underpinned by strategic expansions such as the acquisition of a manufacturing operation from Mercury Mission Systems and entering into a high-value supply agreement expected to bolster revenues substantially. With an annual revenue growth forecast at 11.4%, Cicor not only surpasses the Swiss market's 4.2% but also aligns its R&D pursuits to cater to escalating demands in defense products globally, ensuring sustained technological advancement and market relevance. Click to explore a detailed breakdown of our findings in Cicor Technologies' health report. Examine Cicor Technologies' past performance report to understand how it has performed in the past. Discover the full array of 226 European High Growth Tech and AI Stocks right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:IOT OM:BETCO and SWX:CICN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store